Blood test could personalize chemo for tough breast cancers
NCT ID NCT01349842
Summary
This study tested whether using a blood test to track cancer cells could help doctors choose more effective chemotherapy for women with advanced breast cancer that has spread. It involved 265 women whose cancer had worsened after two prior rounds of chemotherapy. Researchers compared treatment decisions guided by this blood test against the standard method of using scans and symptoms to see if it improved survival and quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER DUCTAL INFILTRATING METASTATIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Georges Francois Leclerc
Dijon, 21079, France
-
Chu Limoges
Limoges, 87042, France
-
Clinique Victor Hugo
Le Mans, 72000, France
-
Hopital Saint Louis
Paris, 75475, France
-
Institut Curie
Paris, 75005, France
-
Institut Rene Huguenin Curie
Saint-Cloud, 92210, France
-
Institut de Canacerologie de L'Ouest
Saint-Herblain, 44805, France
Conditions
Explore the condition pages connected to this study.